Evidence map›Paper›PMID 32050426›Full record

ArticleJournal of clinical medicine2020

Sirtuin 1: Endocan and Sestrin 2 in Different Biological Samples in Patients with Asthma. Does Severity Make the Difference?

Zoe Tsilogianni, Jonathan R Baker, Anastasia Papaporfyriou, Andrianna I Papaioannou, Evgenia Papathanasiou, Nikolaos G Koulouris, Leah Daly, Kazuhiro Ito, Georgios Hillas, Spyridon Papiris and 2 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Roles of sirtuins in asthma.Respiratory research · 2022
    Review
  7. Article
  8. The functions and roles of sestrins in regulating human diseases.Cellular & molecular biology letters · 2022
    Review
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Zoe Tsilogianni2nd Department of Respiratory Medicine, Medical School of National and Kapodistrian University of Athens, "Attikon" Hospital, 12462 Athens, Greece.
Jonathan R BakerAirway Disease, National Heart and Lung Institute, Imperial College, London SW3 6LY, UK.
Anastasia Papaporfyriou1st Department of Respiratory Medicine, Medical School of National and Kapodistrian University of Athens, "Sotiria" Hospital of Chest Diseases, 11527 Athens, Greece.
Andrianna I Papaioannou2nd Department of Respiratory Medicine, Medical School of National and Kapodistrian University of Athens, "Attikon" Hospital, 12462 Athens, Greece.
Evgenia Papathanasiou2nd Department of Respiratory Medicine, Medical School of National and Kapodistrian University of Athens, "Attikon" Hospital, 12462 Athens, Greece.
Nikolaos G Koulouris1st Department of Respiratory Medicine, Medical School of National and Kapodistrian University of Athens, "Sotiria" Hospital of Chest Diseases, 11527 Athens, Greece.
Leah DalyPulmocide Ltd., London SW7 2PG, UK.
Kazuhiro ItoAirway Disease, National Heart and Lung Institute, Imperial College, London SW3 6LY, UK.
Georgios Hillas5th Respiratory Medicine Department, Sotiria Hospital, 11527 Athens, Greece.
Spyridon Papiris2nd Department of Respiratory Medicine, Medical School of National and Kapodistrian University of Athens, "Attikon" Hospital, 12462 Athens, Greece.
Petros Bakakos1st Department of Respiratory Medicine, Medical School of National and Kapodistrian University of Athens, "Sotiria" Hospital of Chest Diseases, 11527 Athens, Greece.
Stelios Loukides2nd Department of Respiratory Medicine, Medical School of National and Kapodistrian University of Athens, "Attikon" Hospital, 12462 Athens, Greece.
National and Kapodistrian University of Athens · GRUniversity General Hospital Attikon · GRImperial College London · GBSotiria General Hospital · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSestrin 2, Endocan, and Sirtuin 1 are distinct molecules with some biologic actions associated with asthma pathophysiology. The aim of the present study was to determine the molecular level differences attributable to underlying asthma severity.

methodsWe initially recruited 85 asthmatics with a wide spectrum of severity. All of the patients were optimally treated according to current guidelines. Demographics, test results of lung function, and treatment regimes of all patients were recorded. Sestrin 2, Endocan, and Sirtuin 1 were measured in different biological samples (sputum with two processing methods and serum).

resultsA total of 60 patients (35 with severe asthma) were analyzed, since 25 patients failed to produce an adequate sample of sputum. Patients with severe asthma showed significantly higher values for Sestrin 2 [pg/mL], measured in both sputum supernatant and cell pellet, compared to those with mild to moderate asthma [9524 (5696, 12,373) vs. 7476 (4265, 9273)

conclusionSestrin 2 is increased in patients with severe asthma as part of a mechanism that may modify structural alterations through the imbalance between oxidative stress and antioxidant activity.

Indexed as

AsthmaEndocaninflammationSestrin 2severitySirtuin 1

Identifiers

PMID32050426
PMCPMC7073772
OpenAlexW3004685273

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.